Product
TBI-1401(HF10)
1 clinical trial
2 indications
Indication
Pancreatic Cancer Stage IIIIndication
Pancreatic CancerClinical trial
Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Patients With Stage III or IV Unresectable Pancreatic Cancer.Status: Active (not recruiting), Estimated PCD: 2020-02-19